2022
DOI: 10.1001/jamahealthforum.2022.0276
|View full text |Cite
|
Sign up to set email alerts
|

Development and Assessment of a New Framework for Disease Surveillance, Prediction, and Risk Adjustment

Abstract: This diagnostic modeling study develops an ICD-10-CM –based classification framework for predicting diverse health care payment, quality, and performance outcomes.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
13
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(16 citation statements)
references
References 15 publications
3
13
0
Order By: Relevance
“…Enrollees with no diagnoses were overpaid by more than $2000 in the HHS HCC model. As previously described, 5 the additive DXI model substantially outperformed the HHS HCC model across the spectrum of common to rare diagnoses.…”
Section: Rare Diagnosessupporting
confidence: 58%
See 3 more Smart Citations
“…Enrollees with no diagnoses were overpaid by more than $2000 in the HHS HCC model. As previously described, 5 the additive DXI model substantially outperformed the HHS HCC model across the spectrum of common to rare diagnoses.…”
Section: Rare Diagnosessupporting
confidence: 58%
“…We used data from 2016 to 2018 of the Merative (formerly IBM) MarketScan Commercial Claims and Encounters Database including 65 901 460 person-years of enrollees 64 years and younger and enrolled in noncapitated commercial insurance plans with medical, pharmacy, and behavioral health benefits. We randomly split the data 90% to 10% for model development and validation, respectively, and used weighted least-squares regression to predict (concurrent) total spending top-coded at $250 000 per person-year, weighting by fraction of the year eligible . The Boston University Institutional Review Board exempted this study of deidentified data from review and informed consent.…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…We use these four metrics that are widely used to evaluate RA models (Ellis et al, 2022): R-squared (R 2 ), also known as Coefficient of Determination, is the proportion of total variance of the target variable explained variance by the model. The exact formula is as follows:…”
Section: Evaluation Metricsmentioning
confidence: 99%